000			02352 a2200625 4500
005			20250515025346.0
264		0	_c20061114
008			200611s 0 0 eng d
022			_a0923-7534
024	7		_a10.1093/annonc/mdj994 _2doi
040			_aNLM _beng _cNLM
100	1		_aCorazzelli, G
245	0	0	_aGemcitabine, ifosfamide, oxaliplatin and rituximab (R-GIFOX), a new effective cytoreductive/mobilizing salvage regimen for relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a pilot study. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _cMay 2006
300			_aiv18-24 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal _xadministration & dosage
650	0	4	_aAntibodies, Monoclonal, Murine-Derived
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aCombined Modality Therapy
650	0	4	_aDeoxycytidine _xadministration & dosage
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aHematopoietic Stem Cell Mobilization
650	0	4	_aHumans
650	0	4	_aIfosfamide _xadministration & dosage
650	0	4	_aLymphoma, B-Cell _xpathology
650	0	4	_aLymphoma, Follicular _xpathology
650	0	4	_aLymphoma, Large B-Cell, Diffuse _xpathology
650	0	4	_aLymphoma, Mantle-Cell _xpathology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Recurrence, Local _xpathology
650	0	4	_aOrganoplatinum Compounds _xadministration & dosage
650	0	4	_aOxaliplatin
650	0	4	_aPilot Projects
650	0	4	_aRemission Induction
650	0	4	_aRituximab
650	0	4	_aSalvage Therapy
650	0	4	_aStem Cell Transplantation
650	0	4	_aSurvival Rate
650	0	4	_aTransplantation, Autologous
650	0	4	_aTreatment Outcome
650	0	4	_aGemcitabine
700	1		_aRusso, F
700	1		_aCapobianco, G
700	1		_aMarcacci, G
700	1		_aDella Cioppa, P
700	1		_aPinto, A
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 17 Suppl 4 _gp. iv18-24
856	4	0	_uhttps://doi.org/10.1093/annonc/mdj994 _zAvailable from publisher's website
999			_c16301902 _d16301902